The FCI is developing individual therapy concepts, which are based on a better understanding of the underlying molecular mechanisms. Interdisciplinary project teams work closely together to achieve the next level of translation in iterative cycles between lab and patient.
„We need to be able to better predict which substances are worth further clinical development. For that, we finally need new, more reliable preclinical models.“
Florian Greten, FCI-Founder
„Individualized therapies can only work if we unravel the underlying molecular mechanisms that drive tumor development and resistance to therapy.“
Ivan Dikic, FCI-Founder
„Interdisciplinary project teams that focus on unresolved clinical issues and elucidate them in molecular detail in iterative cycles between lab and hospital – that’s the only way translation can work.“